Preparation and purification of mupirocin calcium

Details for Australian Patent Application No. 2007291508 (hide)

Owner Xellia Pharmaceuticals ApS

Inventors Aassveen, Lene

Agent Fisher Adams Kelly

Pub. Number AU-B-2007291508

PCT Pub. Number WO2008/025534

Priority 06 17069.0 30.08.06 GB

Filing date 29 August 2007

Wipo publication date 6 March 2008

Acceptance publication date 24 November 2011

International Classifications

C07D 407/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

A61K 31/351 (2006.01) - not condensed with another ring

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2008/025534 Priority application(s): WO2008/025534

20 November 2008 Alteration of Name

  The name of the applicant has been altered to Axellia Pharmaceuticals ApS 2008

21 October 2010 Alteration of Name

  The name of the applicant has been altered to Xellia Pharmaceuticals ApS

24 November 2011 Application Accepted

  Published as AU-B-2007291508

22 March 2012 Standard Patent Sealed

5 July 2012 Assignment Registered

  Xellia Pharmaceuticals ApS The patent has been assigned to Syngen Biotech Co., Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291509-Controlled release oral dosage formulations comprising a core and one or more barrier layers

2007291506-Controlled release solid oral dosage formulations comprising nisoldipine